| Achievements of Transcu Group | |
|---|---|
| May 2009 |
Enhances product prototype and starts additional Phase 2 clinical study for Lidocaine Patch. |
| April 2009 |
Acquisition of 45% Equity Interest in Biomass Energy Corporation. Initiation of Phase 1 Clinical Study in Japan of a Pharmaceutical Drug Formulation which is the subject of the Licensing Agreement with Otsuka Pharmaceutical Co., Ltd concluded in 2007. |
| March 2009 |
Inks MOU with NANOMIZER Inc. to commercialise the Nano-Emulsion Fuel System. Incorporation of a wholly-owned subsidiary in Singapore - Transcu Green Tech Pte. Ltd. |
| February 2009 | Completed private placement of 25M new ordinary shares at S$0.25 for each share and vendor sale of 22M shares by Eng Wah Holdings. Resume trading on 27th Feb 09. |
| November 2008 | Completion of Reverse Takeover. 1st Japanese Life-Sciences company listed on SGX Mainboard. |
| September 2007 | Transcutaneous Technologies, Inc. merged with Ellebeau Inc. and became TTI ellebeau, Inc. |
| June 2007 | Transcu Pte. Ltd. purchased Ellebeau Inc. and made it a wholly owned subsidiary. |
| May 2007 | Concluded a Share Exchange Agreement with Eng Wah Organization Limited for Reverse Takeover. |
| April 2007 | Established Transcu Pte. Ltd. in Singapore. |
| March 2007 | Completed the phase II clinical trials of Lidocaine Patch in the U.S. |
| October 2006 | Completed the phase I clinical trials of Lidoacine Patch in the U.S. |
| December 2005 | GMP facility was established in Seattle, U.S.A by Dharma Therapeutics, Inc. |
| March 2005 | R&D Center was established in Tokyo, Japan, to strengthen R&D. |
| February 2005 | Dharma Therapeutic Inc., was established in Seattle, U.S.A as a wholly owned subsidiary. |
| March 2004 | Transcutaneous Technologies Co., Ltd. was established in Japan. |
| March 1992 | First patent on "Electrophoresis Drug Penetration Device" was applied. |
| June 1988 | Sogo Biyo Ikagaku Kenkyujo was established by Mr Akihiko Matsumura. |